Lichter Jay 4
4 · Janux Therapeutics, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Lichter Jay
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2022-06-14+12,500→ 12,500 totalExercise: $10.73Exp: 2032-06-13→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in equal monthly installments over the 12 months following June 14, 2022, provided that the option will in any case be fully vested on the date of the next annual meeting of the Company's stockholders.